Yankees' Ivan Nova being investigated by MLB

5 Comments

According to a report in the New York Post, MLB is investigating Yankees pitchers Ivan Nova and Wilkin De La Rosa over concerns they injected each other with B-12 shots last year as teammates at Double-A Trenton.
B-12 shots are not included in MLB’s list of prohibited substances, but only licensed physicians are allowed to inject players with medication. Also, according to the Post, MLB wants to confirm that it was, in fact, B-12 the platers were using.
Nova, 23, made his major league debut back in May as a reliever for the Bombers. He was recently recalled to the majors, and he allowed two runs in 5 1/3 innings in a start against the Blue Jays on Monday. The Yankees rewarded him by naming the starter for Sunday’s game against the White Sox.
The 25-year-old De La Rosa is still with Trenton and has a 5.00 ERA in eight starts and 25 relief appearances this year.

Report: White Sox acquire Mark Lowe and Jean Machi from Mariners

Getty Images
Leave a comment

Tacoma Rainiers’ broadcaster Mike Curto reports that the White Sox have acquired veteran right-handed relievers Mark Lowe and Jean Machi from the Mariners in exchange for cash considerations. Neither team has officially confirmed the deal yet.

Lowe, 34, signed a minor league deal with the Mariners in late March. He pitched to a 6.23 ERA in Triple-A Tacoma and tacked on a 4.6 BB/9 and 8.5 SO/9 through 39 innings. He last appeared in the majors with the Tigers, and finished his run in 2016 with a 7.11 ERA through 49 1/3 innings before getting released by the club prior to the 2017 season.

Machi, 35, struggled to find a place in the Mariners’ bullpen this season. A nerve issue in his thumb derailed his efforts at the start of 2017, and he was outrighted to Triple-A after pitching to a 1.17 ERA through 7 2/3 innings in Seattle. In Tacoma, the right-hander’s numbers weren’t too shabby: he split his efforts between the rotation and bullpen and worked a collective 3.44 ERA, 2.0 BB/9 and 7.1 SO/9 through 36 2/3 innings.

Lowe and Machi will help flesh out a White Sox bullpen that has been depleted by recent injuries and trades. They’re expected to report to Chicago’s Triple-A affiliate in Charlotte and could see time in the big leagues by the end of the season.

Yoenis Cespedes: “I’m going to play the last year of my career with Oakland”

Getty Images
3 Comments

Yoenis Cespedes told Susan Slusser of the San Francisco Chronicle that he wants to finish his career with the Athletics, according to an exclusive interview released on Friday. The Mets’ 31-year-old outfielder praised Oakland manager Bob Melvin, telling Slusser, “I don’t think there’s a better manager than Melvin” and adding that while he didn’t know if a return to Oakland would be possible, his love for the city had not faded.

Melvin, for his part, said he wasn’t surprised that the slugger wants another go-round with his first major league club, even if only as a final hurrah. Cespedes hit well over two and a half seasons with the A’s, compiling a cumulative .262/.318/.470 batting line from 2012 to 2014 and enjoying two postseason runs with the club before he was traded for Jon Lester and Jonny Gomes in 2014.

There’s been relatively little for Cespedes to complain about since his departure from Oakland, of course: he turned in a career-best performance in 2015, slashing .291/.328/.542 with 35 home runs and 6.7 fWAR in back-to-back gigs with the Tigers and Mets, and netted a whopping three-year, $75 million contract prior to the 2016 season. Still, there’s something special about the A’s, as the slugger relayed to teammate Jerry Blevins:

I told Blevins, ‘I don’t know how many years I’m going to play, but I’m going to play the last year of my career with Oakland.’ I don’t know if that’s possible or not, but that’s my goal.

Whether or not Cespedes gets his wish, it’s unlikely he’ll pursue any kind of deal with the A’s for the time being. He’s still owed $23.75 million in 2017 and 2018 and isn’t scheduled to hit free agency until 2019.